Endotoxin Testing Market Size, Share, and Trends 2026 to 2035

Endotoxin Testing Market (By Testing Method: Gel Clot Endotoxin Test, Chromogenic Endotoxin Test, Turbidimetric Endotoxin Test; By Product Type: Endotoxin Detection Products, LAL Test Reagents, Mycoplasma Detection and Removal, PCR Mycoplasma Detection Kit, Mycoplasma Elimination Cocktail, Mycoplasma Detection and Elimination Custom Services, Accessories, Instrumentation, Endotoxin Removal Products, Low Endotoxin Recovery (LER) Products, Lipopolysaccharides; By Application; Medical Device Manufacturing, Pharmaceutical Manufacturing, Packaging Manufacture, Raw Materials Production) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2026 to 2035

Last Updated : 23 Feb 2026  |  Report Code : 7822  |  Category : Healthcare   |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Endotoxin Testing Market 

5.1. COVID-19 Landscape: Endotoxin Testing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Endotoxin Testing Market, By Testing Method

8.1. Endotoxin Testing Market, by Testing Method

8.1.1 Gel Clot Endotoxin Test

8.1.1.1. Market Revenue and Forecast

8.1.2. Chromogenic Endotoxin Test

8.1.2.1. Market Revenue and Forecast

8.1.3. Turbidimetric Endotoxin Test

8.1.3.1. Market Revenue and Forecast

Chapter 9. Global Endotoxin Testing Market, By Product Type

9.1. Endotoxin Testing Market, by Product Type

9.1.1. Endotoxin Detection Products

9.1.1.1. Market Revenue and Forecast

9.1.2. LAL Test Reagents

9.1.2.1. Market Revenue and Forecast

9.1.3. Mycoplasma Detection and Removal

9.1.3.1. Market Revenue and Forecast

9.1.4. PCR Mycoplasma Detection Kit

9.1.4.1. Market Revenue and Forecast

9.1.5. Mycoplasma Elimination Cocktail

9.1.5.1. Market Revenue and Forecast

9.1.6. Mycoplasma Detection and Elimination Custom Services

9.1.6.1. Market Revenue and Forecast

9.1.7. Mycoplasma Elimination Cocktail

9.1.7.1. Market Revenue and Forecast

9.1.8. Accessories

9.1.8.1. Market Revenue and Forecast

9.1.9. Instrumentation

9.1.9.1. Market Revenue and Forecast

9.1.10. Low Endotoxin Recovery (LER) Products

9.1.10.1. Market Revenue and Forecast

9.1.11. Lipopolysaccharides

9.1.11.1. Market Revenue and Forecast

Chapter 10. Global Endotoxin Testing Market, By Application

10.1. Endotoxin Testing Market, by Application

10.1.1. Medical Device Manufacturing

10.1.1.1. Market Revenue and Forecast

10.1.2. Pharmaceutical Manufacturing

10.1.2.1. Market Revenue and Forecast

10.1.3. Packaging Manufacture

10.1.3.1. Market Revenue and Forecast

10.1.4. Raw Materials Production

10.1.4.1. Market Revenue and Forecast

Chapter 11. Global Endotoxin Testing Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Testing Method

11.1.2. Market Revenue and Forecast, by Product Type

11.1.3. Market Revenue and Forecast, by Application

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Testing Method

11.1.4.2. Market Revenue and Forecast, by Product Type

11.1.4.3. Market Revenue and Forecast, by Application

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Testing Method

11.1.5.2. Market Revenue and Forecast, by Product Type

11.1.5.3. Market Revenue and Forecast, by Application

11.2. Europe

11.2.1. Market Revenue and Forecast, by Testing Method

11.2.2. Market Revenue and Forecast, by Product Type

11.2.3. Market Revenue and Forecast, by Application

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Testing Method

11.2.4.2. Market Revenue and Forecast, by Product Type

11.2.4.3. Market Revenue and Forecast, by Application

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Testing Method

11.2.5.2. Market Revenue and Forecast, by Product Type

11.2.5.3. Market Revenue and Forecast, by Application

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Testing Method

11.2.6.2. Market Revenue and Forecast, by Product Type

11.2.6.3. Market Revenue and Forecast, by Application

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Testing Method

11.2.7.2. Market Revenue and Forecast, by Product Type

11.2.7.3. Market Revenue and Forecast, by Application

11.3. APAC

11.3.1. Market Revenue and Forecast, by Testing Method

11.3.2. Market Revenue and Forecast, by Product Type

11.3.3. Market Revenue and Forecast, by Application

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Testing Method

11.3.4.2. Market Revenue and Forecast, by Product Type

11.3.4.3. Market Revenue and Forecast, by Application

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Testing Method

11.3.5.2. Market Revenue and Forecast, by Product Type

11.3.5.3. Market Revenue and Forecast, by Application

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Testing Method

11.3.6.2. Market Revenue and Forecast, by Product Type

11.3.6.3. Market Revenue and Forecast, by Application

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Testing Method

11.3.7.2. Market Revenue and Forecast, by Product Type

11.3.7.3. Market Revenue and Forecast, by Application

11.4. MEA

11.4.1. Market Revenue and Forecast, by Testing Method

11.4.2. Market Revenue and Forecast, by Product Type

11.4.3. Market Revenue and Forecast, by Application

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Testing Method

11.4.4.2. Market Revenue and Forecast, by Product Type

11.4.4.3. Market Revenue and Forecast, by Application

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Testing Method

11.4.5.2. Market Revenue and Forecast, by Product Type

11.4.5.3. Market Revenue and Forecast, by Application

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Testing Method

11.4.6.2. Market Revenue and Forecast, by Product Type

11.4.6.3. Market Revenue and Forecast, by Application

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Testing Method

11.4.7.2. Market Revenue and Forecast, by Product Type

11.4.7.3. Market Revenue and Forecast, by Application

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Testing Method

11.5.2. Market Revenue and Forecast, by Product Type

11.5.3. Market Revenue and Forecast, by Application

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Testing Method

11.5.4.2. Market Revenue and Forecast, by Product Type

11.5.4.3. Market Revenue and Forecast, by Application

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Testing Method

11.5.5.2. Market Revenue and Forecast, by Product Type

11.5.5.3. Market Revenue and Forecast, by Application

Chapter 12. Company Profiles

12.1. Charles River Laboratories International, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Lonza Group Ltd.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Merck KGaA

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Thermo Fisher Scientific Inc

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. bioMerieux SA

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Eurofins Scientific SE

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Associates of Cape Cod, Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. FUJIFILM Wako Pure Chemical Corporation

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. WuXi AppTec Co. Ltd.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Sartorius AG

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The endotoxin testing market size was evaluated at USD 1.45 billion in 2025 and is predicted to hit around USD 3.78 billion by 2035.

Answer : The endotoxin testing market is expected to grow at a compound annual growth rate (CAGR) of around 10.05% from 2026 to 2035.

Answer : The major players in the endotoxin testing market include Charles River Laboratories International, Inc., Lonza Group Ltd., Merck KGaA, Thermo Fisher Scientific Inc, bioMérieux SA, Eurofins Scientific SE, Associates of Cape Cod, Inc., FUJIFILM Wako Pure Chemical Corporation, WuXi AppTec Co. Ltd., Sartorius AG, Bio-Rad Laboratories, Inc., SGS Société Générale de Surveillance SA, Nelson Laboratories, LLC, GenScript Biotech Corporation, and Maravai LifeSciences Holdings, Inc.

Answer : The driving factors of the endotoxin testing market are the increasing demand for safe pharmaceuticals, biologics, and medical devices, coupled with stringent regulatory standards for contamination control.

Answer : North America region will lead the global endotoxin testing market during the forecast period 2026 to 2035.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client